← Evidence map

ArticleFrontiers in medicine2023

What did we learn about tocilizumab use against COVID-19? A single-center observational study from an intensive care unit in Serbia.

Tatjana Adzic-Vukicevic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 38034537